Agenus (AGEN) Other Non Operating Income (2018 - 2026)
Agenus (AGEN) posted quarterly Other Non Operating Income of $38.8 million for Q1 2026, up 14804.92% year-over-year from N/an in Q1 2025, and up 531.78% quarter-over-quarter from -$9.0 million in Q4 2025.
Analysis
Agenus (AGEN) Other Non Operating Income (2018 - 2026) Analysis & Trends
Agenus' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $38.8 million for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 14804.92% year-over-year to $38.8 million; the TTM figure through Mar 2026 stood at $111.4 million (up 1570.32% YoY), while the FY2025 annual figure was $72.4 million, up 1141.15% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $38.8 million, up from -$9.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was $81.6 million in Q3 2025, with the low at -$9.0 million in Q4 2025.
- The 3-year median for Other Non Operating Income is -$12000.0 (2025), against an average of $13.0 million.
- Peak annual rise in Other Non Operating Income reached 429510.53% in 2025, while the deepest fall reached 3913.84% in 2025.
- Agenus' Other Non Operating Income stood at -$224000.0 in 2024, then plunged by 3913.84% to -$9.0 million in 2025, then surged by 531.78% to $38.8 million in 2026.
- Business Quant data shows AGEN's Other Non Operating Income at $38.8 million in Q1 2026, -$9.0 million in Q4 2025, and $81.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Agenus | 340.21 Mn | 340.21 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 38.82 Mn |
| Dec 31, 2025 | -8.99 Mn |
| Sep 30, 2025 | 81.63 Mn |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | -264,000.00 |
| Dec 31, 2024 | -224,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 7.14 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Sep 30, 2021 | 6.20 Mn |
| Dec 31, 2020 | 5.42 Mn |
| Mar 31, 2020 | -2.72 Mn |
| Mar 31, 2018 | -10.77 Mn |